SCMOM 2012_StemBioSys
StemBioSys is a development-stage company with novel technologies to isolate and expand specialized stem cell (SC) populations, including large numbers of elusive, pluri-potent, embryonic-like stem cells (ELSCs) from cord blood. The core technology platform is a patented ECM, produced by bone marrow MSCs, which replicates their native microenvironment, promotes proliferation of various SC beyond current methods and preserves SC phenotypes ("stemness"). StemBioSys ELSCs have generated tissues in vivo from all three germ layers, providing a viable research and clinical alternative to both hESCs and iPS cells. These technologies help overcome major obstacles to developing autologous and allogenic stem cell therapies. http://www.stembiosys.com Presenter: Steven Davis, CEO, StemBioSysFrom:AllianceRegenMedViews:3 1ratingsTime:13:08More inScience Technology
Read this article:
SCMOM 2012_StemBioSys - Video